Related Experiment Video
Updated: Nov 5, 2025
07:40
Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
1.4K
IL-22 ameliorated cardiomyocyte apoptosis in cardiac ischemia/reperfusion injury by blocking mitochondrial membrane
Summary
Interleukin-22 (IL-22) protects heart cells from death after injury. This finding offers a new therapeutic strategy for heart failure by controlling cardiomyocyte apoptosis.
Area of Science:
- Cardiology
- Immunology
- Cell Biology
Background:
- Cardiomyocyte death is a primary driver of heart failure post-cardiac injury.
- Interleukin-22 (IL-22) is crucial for tissue repair and homeostasis.
- The role of IL-22 in preventing cardiac injury-induced cardiomyocyte apoptosis is unknown.
Purpose of the Study:
- To investigate the protective effects of IL-22 against cardiomyocyte apoptosis in cardiac injury.
- To elucidate the underlying mechanisms of IL-22's action in the heart.
Main Methods:
- In vitro studies using Angiotensin II to induce cardiomyocyte apoptosis.
- In vivo animal models of cardiac injury.
- Analysis of patient samples.
- Assays for superoxide dismutase (SOD) activity, mitochondrial membrane potential, reactive oxygen species (ROS) production, and cytochrome C release.
Main Results:
- IL-22 significantly inhibited Angiotensin II-induced cardiomyocyte apoptosis in vitro.
- IL-22 enhanced SOD activity and mitochondrial membrane potential.
- IL-22 reduced ROS production and cytochrome C release.
- Similar protective effects were observed in vivo and in human patients.
Conclusions:
- IL-22 demonstrates a protective effect against cardiomyocyte apoptosis following cardiac injury.
- IL-22 acts by improving antioxidant capacity and maintaining mitochondrial function.
- IL-22 represents a potential therapeutic target for treating heart injury and preventing heart failure.
